23/04/2014 07:23:28 Free Membership Login

   

Acorda Therapeutics, Inc.

Visual Financials
Company Name: Acorda Therapeutics, Inc.
Ticker Symbol: ACOR
WWW Address: http://www.acorda.com
CEO: Ron Cohen
No. of Employees: 378
Common Issue Type: CS
Business Description:Acorda Therapeutics, Inc. is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and disorders of the central nervous system.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 35.78 Up 0.69 32.0 36.45 35.33 36.39 35.15 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,478.1 41.3 0.00 0.41 0.00 85.7 0.0 40.87 - 27.51
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close35.77$
PE Ratio - LTM85.7
Market Capitalisation1,478.1mil
Latest Shares Outstanding41.3mil
Earnings pS (EPS)0.41$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee809,032$
Effective Tax Rate0.0%
Float35.3mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.60%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin80.2%
EBITDA Margin11.3%
Pre-Tax Profit Margin0.0%
Assets Turnover57.4%
Return on Assets (ROA)2.8%
Return on Equity (ROE)4.0%
Return on Capital Invested (ROCI)3.6%
Current Ratio3.8
Leverage Ratio (Assets/Equity)1.4
Interest Cover14.3
Total Debt/Equity (Gearing Ratio)0.01
LT Debt/Total Capital1.0%
Working Capital pS6.55$
Cash pS0.00$
Book-Value pS10.66$
Tangible Book-Value pS10.24$
Cash Flow pS0.94$
Free Cash Flow pS0.77$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.29
Price/Tangible Book Ratio0.00
Price/Cash Flow37.3
Price/Free Cash Flow45.7
P/E as % of Industry Group35.0%
P/E as % of Sector Segment7.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----0.1-2556,547840,685
4 Weeks39.6234.0039.09-10.2-11509,84510,196,910
13 Weeks39.9528.3431.5911.19516,62433,063,938
26 Weeks39.9527.5132.717.3470,75458,844,318
52 Weeks40.8727.5139.22-10.5-30401,823101,259,452
YTD39.9527.51-21.219499,27237,944,746
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
35.1935.9436.6333.4934.190.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.480.60.21
Income0.0
Dividend0.0
Capital SpendingNA
R&D13.69NA18.15
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %0.90.94.6
Earnings %-100.0-100.0406.3
EPS %-100.0-100.0405.3
EPS $-0.22-0.223.08
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio41.43
Current Ratio3.4
Quick Ratio (Acid Test)2.6
Liquidity Ratio (Cash)2.37
Receivables Turnover12.4
Average Collection Period29
Working Capital/Equity60.7
Working Capital pS5.89
Cash-Flow pS4.12
Free Cash-Flow pS0.97
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio6.39
Financial Leverage Ratio (Assets/Equity)1.5
Debt Ratio31.7
Total Debt/Equity (Gearing Ratio)0.01
LT Debt/Equity0.01
LT Debt/Capital Invested20.6
LT Debt/Total Liabilities2.5
Interest Cover13.9
Interest/Capital Invested0.40
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio2.57
Current P/E Ratio - LTM85.70
Enterprise Value (EV)/EBITDA40.22
Enterprise Value (EV)/Free Cash Flow39.50
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.29
Price/Cash Flow Ratio37.3
Price/Free Cash Flow Ratio - LTM45.7
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM9.6
P/E Ratio (26 weeks ago) - LTM29.6
P/E Ratio (52 weeks ago) - LTM24.7
5-Y High P/E Ratio103.6
5-Y Low P/E Ratio39.3
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E25
P/E as % of Industry Group35.0
P/E as % of Sector Segment7.0
Current 12 Month Normalized P/E Ratio - LTM9.4
PER SHARE FIGURES
LT Debt pS0.11
Current Liabilities pS2.48
Tangible Book Value pS - LTM10.24
Book Value pS - LTM10.66
Capital Invested pS9.45
Cash pS - LTM0.00
Cash Flow pS - LTM0.94
Free Cash Flow pS - LTM0.77
Earnings pS (EPS)0.41
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin12.60
Free Cash Flow Margin 5YEAR AVG-6.49
Net Profit Margin50.7
Net Profit Margin - 5YEAR AVRG.-0.2
Equity Productivity0.79
Return on Equity (ROE)40.2
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.78
Return on Capital Invested (ROCI)39.7
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.60
Return on Assets (ROA)27.4
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin80.2
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM11.3
EBIT Margin - LTM9.2
Pre-Tax Profit Margin7.9
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate-538.5
Effective Tax Rate - 5YEAR AVRG.-106.8
EFFICIENCY RATIOS
Cash Conversion Cycle214
Revenue per Employee809,032
Net Income per Employee409,942
Average Collection Period31
Receivables Turnover12.4
Day's Inventory Turnover Ratio183
Inventory Turnover2.0
Inventory/Sales6.9
Accounts Payble/Sales10.36
Assets/Revenue1.67
Net Working Capital Turnover1.31
Fixed Assets Turnover1.32
Total Assets Turnover0.6
Revenue per $ Cash7.30
Revenue per $ Plant18.31
Revenue per $ Common Equity0.79
Revenue per $ Capital Invested0.78
Selling, General & Adm/tive (SG&A) as % of Revenue55.2
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue17.6
R&D Expense as % of Revenue - 5YEAR AVRG.17.6

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq acor140423 07:23